Alberta Investment Management Corp (AIMCo)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,127	Closed	-$476K	–	1281
2022 Q4	$476K	Buy	+7,127	New	+$476K	﹤0.01%	926
2019 Q3	–	Sell	-11,381	Closed	-$810K	–	960
2019 Q2	$810K	Sell	11,381 -23,564	-67%	-$1.68M	0.01%	682
2019 Q1	$2.74M	Buy	+34,945	New	+$2.74M	0.03%	419